Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Spiropiperidine compounds as ORL-1 receptor antagonists

Spiropiperidine compounds as ORL-1 receptor antagonists

US Patent 8232289 · Granted Jul 31, 2012

Estimated economic value: $213,592,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Ghrelin 0-acyl transferase inhibitors2019
Ghrelin O-acyl transferase inhibitors2018
DGAT2 inhibitors2018
2-oxo-1,3,8-triazaspiro[4.5]decan-3-yl] carboxylic acid derivatives2018
Benzyl sulfonamide compounds useful as MoGAT-2 inhibitors2016
Ghrelin O-acyl transferase inhibitor2015
6-arylalkylamino-2,3,4,5-tetrahydro-1H-benzo[d]azepines as 5-HT2C receptor agoni2014
6 substituted 2, 3,4,5 tetrahydro-1H-benzo[d]azepines as 5-HT2C receptor agonist2013
6-substituted-2,3,4,5-tetrahydro-1H-benzo[d]azepines as 5-HT2C receptor agonists2013
Kappa selective opioid receptor antagonist2012
Kappa selective opioid receptor antagonist2012
6-substituted 2,3,4,5-tetrahydro-1H-benzo[d]azepines as 5-HT2C receptor agonists2011